Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

37.50
-0.2100-0.56%
Post-market: 37.25-0.2500-0.67%19:56 EDT
Volume:869.00K
Turnover:32.65M
Market Cap:6.92B
PE:-21.06
High:38.35
Open:37.78
Low:37.04
Close:37.71
52wk High:59.62
52wk Low:27.34
Shares:184.57M
Float Shares:81.22M
Volume Ratio:0.67
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7807
EPS(LYR):-0.9681
ROE:-29.65%
ROA:-7.81%
PB:6.68
PE(LYR):-38.73

Loading ...

Legend Biotech’s Earnings Call: Growth and Success

TIPRANKS
·
Aug 13

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 12

Legend Biotech price target raised to $77 from $75 at RBC Capital

TIPRANKS
·
Aug 12

RBC Capital Adjusts Price Target on Legend Biotech to $77 From $75, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

Legend Biotech’s Strategic Growth and Record Sales Drive Buy Rating

TIPRANKS
·
Aug 12

Strong Buy Rating for Legend Biotech Driven by CARVYKTI’s Market Success and Strategic Expansions

TIPRANKS
·
Aug 12

Barclays Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Legend Biotech’s Hold Rating: Balancing Strong Revenue Growth with Strategic Uncertainties

TIPRANKS
·
Aug 12

Sector Update: Health Care Stocks Rise Premarket Monday

MT Newswires Live
·
Aug 11

Legend Biotech Reports Q2 2025 Results: Adjusted Net Income of $10.1M, Collaboration Revenue Soars to $219.7M

Reuters
·
Aug 11

Legend Biotech Q2 EPS $(0.34) Misses $(0.14) Estimate, Sales $255.058M Beat $234.236M Estimate

Benzinga
·
Aug 11

Legend Biotech Corporation Q2 Net Income USD -125.38 Million

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 EPS USD -0.34

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 Adjusted EPS USD 0.03

THOMSON REUTERS
·
Aug 11

Legend Biotech Corp - FDA Removes Rems for Bcma & Car T Cell Therapies Including Carvykti

THOMSON REUTERS
·
Aug 11

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

GlobeNewswire
·
Aug 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 08

Here's Why Legend Biotech (NASDAQ:LEGN) Can Manage Its Debt Despite Losing Money

Simply Wall St.
·
Aug 05

Legend Biotech Corporation to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 28

Legend Biotech (LEGN) Receives a Buy from Goldman Sachs

TIPRANKS
·
Jul 17